Pacifico Biolabs Raises €7M for Mycelium Protein Production

German food technology innovator, Pacifico Biolabs, has successfully closed a Series A funding round, raising €7 million. This significant capital injection is earmarked for scaling its unique approach to alternative protein production, which leverages the existing infrastructure of breweries.

The company's proprietary technology utilizes mycelium fermentation to create novel protein ingredients. By repurposing established brewing facilities, Pacifico Biolabs aims to bypass the substantial capital expenditure typically associated with building dedicated bioreactor plants. This strategy offers a more sustainable and cost-effective pathway to market for alternative proteins, a sector experiencing rapid global expansion driven by consumer demand for plant-based and environmentally conscious food options.

The investment round saw participation from a strong syndicate of investors, underscoring confidence in Pacifico Biolabs' innovative model. Key backers include Stray Dog Capital, TGFS, Sprout & About Ventures, Simon Capital, and FoodLabs. The involvement of a regional brewery partner further validates the company's operational strategy and its potential for seamless integration within the existing food and beverage industry.

This funding comes at a pivotal moment for the alternative protein market, which is projected to reach hundreds of billions of dollars globally within the next decade. Traditional protein sources face increasing scrutiny regarding their environmental footprint, creating a fertile ground for disruptive technologies like that of Pacifico Biolabs. The company's focus on mycelium, a versatile fungal network, allows for the production of proteins with desirable textures and nutritional profiles, suitable for a wide range of food applications.

With the newly acquired capital, Pacifico Biolabs plans to enhance its production capabilities and further develop its product pipeline. The strategic use of brewery infrastructure not only reduces upfront investment but also potentially shortens time-to-market, a critical factor in the fast-paced food tech sector. This approach could set a new precedent for how alternative protein companies establish and scale their operations.

The broader implications of this funding extend to the circular economy and sustainable manufacturing. By utilizing existing industrial assets and potentially byproducts from brewing processes, Pacifico Biolabs is positioning itself as a leader in resource-efficient food production. This aligns with growing investor interest in cleantech and climate-focused ventures, as the food industry seeks to mitigate its environmental impact.